|Published||Report Code||Available Format|
D-Amino Acid Market Overview
Continuous research and development to bring down the cost of production of the acid through the adoption of advanced technologies is a key trend witnessed in the D-amino acid market. The conventional manufacturing of the acid is a tedious process, which requires a lot of time. Hence, new methods, such as the enzymatic process, are being adopted to simplify the production of the acid.
D-amino acid is a constituent of natural peptides and is produced by microorganisms through the non-ribosomal mechanism. The D-amino acid market is expected to grow on account of the growing usage of the acid in various medicines and food products.
On the basis of product, the D-amino acid market is categorized into D-alanine, D-glutamic acid, D-aspartic acid, D-methionine, D-threonine, D-tryptophan, D-leucine, D-phenylalanine, and D-valine.
Based on end-use industry, the D-amino acid market is categorized into food and beverages, pharmaceuticals, cosmetics, and animal feed. Of these, the pharmaceuticals industry held a significant share in the market during the historical period, as the product is widely used in the production of a wide range of medicines. Moreover, easy accessibility of medicines is likely to boost the medicine production, which, in turn, would support the market growth during the forecast period.
Based on region, the market is categorized into Europe, North America, Asia-Pacific (APAC), Latin America, and the Middle East and Africa. Globally, APAC held a significant share in the D-amino acid market during the historical period. The market in the region is primarily driven by the demand for the product from end-use industries such as pharmaceuticals, and food and beverages. In the coming years, the region will continue holding a considerable share in the global D-amino acid industry on account of the rapid expansion in the healthcare sector of countries such as China, India, and Vietnam.
D-Amino Acid Market Dynamics
The major factor driving the growth of the D-amino acid market is the rapid expansion of the healthcare sector. The acid is majorly utilized in the production of peptide-based drugs, which possess synthesizing properties and are used in the treatment of tumors and Alzheimer's disease. D-amino acid-based peptides are also used in synthetic peptide anti-pain analgesics and synthetic peptide protease inhibitors, which are used in the field of keratotomy. These acids help in the early detection of Alzheimer's disease. Thus, expansion in healthcare sector, complemented by the increase in the production of peptides, is expected to continue boosting the demand for D-amino acid in the coming years.
The major factor restraining the growth of the D-amino acid market is the rise in the price of raw materials that are used in the production of the acid. The rise in raw material prices is expected to result in the increased cost of production in the coming years. The increased cost of production will eventually affect the profitability of the companies, compelling them to delay their expansion plans. This, in turn, would restrict the product supply, thus limiting the market growth to some extent.
With economic development, the demand for cosmetics, and food and beverages is growing exponentially in emerging economies. The growth in end-use industries in APAC countries such as China and India is supporting the D-amino acid market. In the coming years, emerging countries are expected to witness rise in the middle-class population, which will further boost the demand for cosmetics and food items in these countries. Thus, the rising demand for the acid from end-use industries will offer ample growth opportunities to the players operating in the market.
D-Amino Acid Market Competitive Landscape
A large number of companies operating in the D-amino acid market have their production facilities in the APAC region. Most of these companies are multinational corporations having significant presence across several countries of the world. Some of the major market players are Sichuan Tongsheng Amino acid Co. Ltd., Tokyo Chemical Industry Co. Ltd., Yoneyama Yakuhin Kogyo Co. Ltd., Evonik Industries AG, Zhangjiagang Huachang Pharmaceutical Co. Ltd., Central Drug House (P) Ltd., Sekisui Medical Co. Ltd., Kyowa Hakkon Kirin Co. Ltd., AnaSpec Inc., and Varsal Chemicals.
The study provides the historical as well the forecast market size data for various countries, including the U.S., Canada, France, Germany, the U.K., Italy, Spain, Japan, China, India, Brazil, Saudi Arabia, and South Africa.